Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Hutchmed (HCM) Share News

Hutchmed drug approved in China for liver cancer

28th Aug 2026 11:54

(Alliance News) - Hutchmed China Ltd on Friday announced regulatory approval for fanregratinib in China for the treatment of intrahepatic cholangiocarcinoma, a rare cancer that develops in the bile ducts. Read More

LONDON BRIEFING: Goodwin ups payout; McBride hails deal win

28th Aug 2026 07:51

(Alliance News) - Goodwin hails record annual profit as a process to sell a unit progresses, Morgan Advanced Materials has exited an investee, netting over GBP50 million, while McBride has secured a deal with a former Reckitt unit. Read More

AstraZeneca halts lung trial as two cancer drugs show positive results

17th Aug 2026 09:43

(Alliance News) - AstraZeneca PLC on Monday announced it is discontinuing the eVOLVE-Lung02 phase III trial after an independent review found its experimental drug volrustomig was unlikely to improve outcomes against the comparator treatment. Read More

UK earnings, trading statements calendar - next 7 days

23rd Jul 2026 12:56

Hutchmed drug approved in China for advanced gastric cancer

2nd Jul 2026 14:26

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer with "a very poor prognosis". Read More

LONDON MARKET MIDDAY: FTSE 100 rises ahead of crucial US jobs report

2nd Jul 2026 12:07

(Alliance News) - Stock prices in London were mixed at midday on Thursday, as the FTSE 100 outperformed the mid-cap index as investors focused on the upcoming US jobs report for further clues on the Federal Reserve's interest rate path. Read More

WINNERS & LOSERS: Capricorn jumps after agreeing to Genel takeover

2nd Jul 2026 11:04

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

Hutchmed China reports positive phase two fanregratinib study data

25th Jun 2026 11:25

(Alliance News) - Hutchmed China Ltd on Thursday reported positive phase two data for fanregratinib in patients with intrahepatic cholangiocarcinoma, showing clinically meaningful and durable responses in a registration-enabling study. Read More

Hutchmed highlights data for sovleplenib in rare blood disorder

12th Jun 2026 16:24

(Alliance News) - Hutchmed China Ltd on Friday said phase III trial results for its investigational drug sovleplenib showed significant efficacy and a favourable safety profile in patients with warm antibody autoimmune hemolytic anaemia, or wAIHA. Read More

TRADING UPDATES: Tungsten secures loan; Ashtead trading in line

21st May 2026 16:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

5th May 2026 13:13

EARNINGS AND TRADING: AltynGold reports annual revenue surge

29th Apr 2026 19:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Hutchmed begins phase-three trials of lymphoma therapy in China

23rd Mar 2026 10:21

(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

FTSE 100 Latest

Value10,824.26

Change31.72